Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Gowling Lafleur Henderson LLP

02 9Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2222524

Filing Date : 1996-06-28

Strength per Unit : 20 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2016-06-28

Date Granted : 2010-01-26

blank

02

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2416293

Filing Date : 2001-07-30

Strength per Unit : 20 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2021-07-30

Date Granted : 2011-05-10

blank

03

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2541944

Filing Date : 2004-11-12

Strength per Unit : 20 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2024-11-12

Date Granted : 2014-02-25

blank

04

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2222524

Filing Date : 1996-06-28

Strength per Unit : 40 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2016-06-28

Date Granted : 2010-01-26

blank

05

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2416293

Filing Date : 2001-07-30

Strength per Unit : 40 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2021-07-30

Date Granted : 2011-05-10

blank

06

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2541944

Filing Date : 2004-11-12

Strength per Unit : 40 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2024-11-12

Date Granted : 2014-02-25

blank

07

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2416293

Filing Date : 2001-07-30

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2021-07-30

Date Granted : 2011-05-10

blank

08

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2541944

Filing Date : 2004-11-12

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2024-11-12

Date Granted : 2014-02-25

blank

09

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2222524

Filing Date : 1996-06-28

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2016-06-28

Date Granted : 2010-01-26

blank

10

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

Pasireotide Pamoate

Brand Name : SIGNIFOR LAR

Patent Number : 2683935

Filing Date : 2008-05-23

Strength per Unit : 20 mg / vial

Dosage Form : POWDER FOR SUSPENSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2028-05-23

Date Granted : 2016-07-19

blank